Your browser doesn't support javascript.
loading
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.
Diamantidis, Clarissa J; Bosworth, Hayden B; Oakes, Megan M; Davenport, Clemontina A; Pendergast, Jane F; Patel, Sejal; Moaddeb, Jivan; Barnhart, Huiman X; Merrill, Peter D; Baloch, Khaula; Crowley, Matthew J; Patel, Uptal D.
Afiliação
  • Diamantidis CJ; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Division of Nephrology, Duke University School of Medicine, Durham, NC, United States. Electronic address: clarissa.diamantidis@duke.edu.
  • Bosworth HB; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Center for Health Services Research in Primary Medicine, Durham VAMC, United States; Department of Population Health Science, Duke University School of Medicine, Durham, NC, United States.
  • Oakes MM; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Department of Population Health Science, Duke University School of Medicine, Durham, NC, United States.
  • Davenport CA; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.
  • Pendergast JF; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.
  • Patel S; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States.
  • Moaddeb J; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC, United States.
  • Barnhart HX; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Merrill PD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Baloch K; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Crowley MJ; Division of Endocrinology, Duke University School of Medicine, Durham, NC, United States.
  • Patel UD; Division of Nephrology, Duke University School of Medicine, Durham, NC, United States; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States; Gilead Sciences, Inc, Foster City, CA, United States.
Contemp Clin Trials ; 69: 28-39, 2018 06.
Article em En | MEDLINE | ID: mdl-29649631
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Educação de Pacientes como Assunto / Telemedicina / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Educação de Pacientes como Assunto / Telemedicina / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article